New polio vaccine combo tested in infants: could speed up eradication
NCT ID NCT06895486
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether giving two new oral polio vaccines (types 1 and 2) together is safe and works as well as giving them separately in healthy 16-week-old infants. About 675 babies in Panama will receive either the combo or single vaccines. The goal is to see if the combo approach can simplify vaccination and help wipe out polio for good.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Novel Oral Polio Vaccine Type 1 and Type 2 (nOPV1 and nOPV2)
What this could lead to
If successful, this could lead to a more efficient way to protect infants against polio by giving two vaccine types at once, helping to eradicate polio globally.
What could go wrong
This is a phase 2 trial with 675 infants, so it's still early. The vaccines may not work as well when given together, or could cause more side effects. Results may not apply to other populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLIOMYELITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cevaxin - 24 de Diciembre
RECRUITINGPanama City, Panama
Contact
-
Cevaxin - Ave. México
RECRUITINGPanama City, Panama
Contact
-
Cevaxin - Chorrera
RECRUITINGPanama City, Panama
Contact